$STXS
Stereotaxis, Inc. Common Stock
XASE•Health Care•Electromedical & Electrotherapeutic Apparatus
Why is STXS down today? It is at $1.42 (-1.39%), and our scanner flagged it 10 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment STXS spikes, and full due diligence on STXS — key stats, earnings, dilution and insider activity. Free.
Get free $STXS alerts the moment volume spikes
Our scanner flagged $STXS 10 times in the last 30 days. Create a free account to track $STXS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $1.42
- Change today
- -1.39%
- Previous close
- $1.44
- 52-week range
- $1.24 – $3.59
- Market cap
- $142M
- Total held
- 15.6%
- Tradeable float
- 84.6M 84% of shares · after 16% insiders + institutional n/a
- Short interest
- 4.5M ▲ +1% vs prior · as of 2026-07-31
- Short % of float
- 5.3%
- Days to cover
- 2.5d
- Avg daily volume
- 569K
- Sector
- Health Care
- Industry
- Electromedical & Electrotherapeutic Apparatus
- Exchange
- XASE
- 5mthin
- 0.1x
- 15mthin
- 0.1x
- 1hthin
- 0.1x
- 1D
- --
Get free STXS + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $STXS down today?
Here is the latest on STXS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for STXS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Insiders
Insiders buying6 buys, 0 sells last 3 months (14/0 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Curet Myriam Director | Acquired (grant/award) | +43K 0.04% of company | added 11% | 435K | n/a | Jul 1, 26 |
Menawat Arun Swarup Director | Acquired (grant/award) | +43K 0.04% of company | added 4.3% | 1.04M | n/a | Jul 1, 26 |
Fischel Nathan Director | Acquired (grant/award) | +43K 0.04% of company | added 6.4% | 721K | n/a | Jul 1, 26 |
Levin Ross B Director | Acquired (grant/award) | +43K 0.04% of company | added 7.5% | 621K | n/a | Jul 1, 26 |
Shamir Nachum Director | Acquired (grant/award) | +43K 0.04% of company | added 32% | 179K | n/a | Jul 1, 26 |
Benfer David Director | Acquired (grant/award) | +43K 0.04% of company | added 8.4% | 559K | n/a | Jul 1, 26 |
Fischel Nathan Director | Acquired (grant/award) | +47K 0.05% of company | added 7.4% | 678K | n/a | Jan 2, 26 |
Levin Ross B Director | Acquired (grant/award) | +47K 0.05% of company | added 8.8% | 578K | n/a | Jan 2, 26 |
Shamir Nachum Director | Acquired (grant/award) | +47K 0.05% of company | added 53% | 136K | n/a | Jan 2, 26 |
Curet Myriam Director | Acquired (grant/award) | +47K 0.05% of company | added 14% | 392K | n/a | Jan 2, 26 |
Benfer David Director | Acquired (grant/award) | +47K 0.05% of company | added 10% | 516K | n/a | Jan 2, 26 |
Menawat Arun Swarup Director | Acquired (grant/award) | +47K 0.05% of company | added 5.0% | 992K | n/a | Jan 2, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Active shelfAt-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing). If $STXS runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- 76,432,947 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time
- At-the-market (ATM) program — sells new shares into the market gradually over time
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$STXS Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$STXS Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Stocks similar to STXS
Comparable names in electromedical & electrotherapeutic apparatus, closest in size first.
STXS stock FAQ
Why is $STXS down today?
Here is the latest on STXS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for STXS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the STXS stock price today?
STXS last traded at $1.42, down 1.39% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live STXS alerts?
The STXS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged STXS 10 times in the last 30 days.
What exchange is STXS on?
STXS (Stereotaxis, Inc. Common Stock) trades on XASE, with a market cap of about $142M in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS sector.
Is STXS good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge STXS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.